Koppel; Gary A.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Koppel; Gary A..The latest application filed is for "neurotherapeutic treatment for sexual dysfunction".
Company Profile
0.26.28
- Koppel; Gary A. - Indianapolis IN
- Koppel; Gary A. - Indiannapolis IN
- Koppel; Gary A - Indianapolis IN
Patent Activity
| Patent | Date |
|---|---|
| Beta-lactamylalkanoic acids for treating premenstrual disorders Grant 9,597,314 - Koppel , et al. March 21, 2 | 2017-03-21 |
| Neurotherapeutic Treatment For Sexual Dysfunction App 20130131032 - Koppel; Gary A. | 2013-05-23 |
| .beta.-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists Grant 8,426,400 - Koppel , et al. April 23, 2 | 2013-04-23 |
| Beta-lactamyl Phenylalanine, Cysteine, And Serine Vasopressin Antagonists App 20120220765 - KOPPEL; Gary A. ; et al. | 2012-08-30 |
| Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists Grant 8,048,874 - Koppel , et al. November 1, 2 | 2011-11-01 |
| Neurotherapeutic Treatment For Sexual Dysfunction App 20110257147 - Koppel; Gary A. | 2011-10-20 |
| Neurotherapeutic treatment for sexual dysfunction Grant 7,998,991 - Koppel August 16, 2 | 2011-08-16 |
| Beta-LACTAMYL VASOPRESSIN V1a ANTAGONISTS App 20110059935 - Bruns, JR.; Robert F. ; et al. | 2011-03-10 |
| Neurotherapeutic Cephalosporin Sulfoxide and Sulfone-Containing Compositions App 20110046103 - Koppel; Gary A. ; et al. | 2011-02-24 |
| Neurotherapeutic compositions and method Grant 7,842,683 - Koppel November 30, 2 | 2010-11-30 |
| Oral neurotherapeutic cephalosporin sulfoxide and sulfone-containing compositions Grant 7,833,998 - Koppel , et al. November 16, 2 | 2010-11-16 |
| Neurotherapeutic Composition And Method Therefor App 20100249090 - Koppel; Gary A. ; et al. | 2010-09-30 |
| Neurotherapeutic compositions App 20100099656 - Koppel; Gary A. | 2010-04-22 |
| Beta-lactam Cannabinoid Receptor Modulators App 20100016274 - Koppel; Gary A. ; et al. | 2010-01-21 |
| Beta-lactamylalkanoic Acids For Treating Premenstrual Disorders App 20090170825 - Koppel; Gary A. ; et al. | 2009-07-02 |
| Beta-Lactamyl Phenylalanine, Cysteine, and Serine Vasopressin Antagonists App 20080280870 - Koppel; Gary A. ; et al. | 2008-11-13 |
| Neurotherapeutic Compositions and Method App 20080200447 - Koppel; Gary A. | 2008-08-21 |
| Oral Neurotherapeutic Cefazolin Compositons App 20080176825 - Koppel; Gary A. ; et al. | 2008-07-24 |
| {Beta}-Lactamyl vasopression V1a antagonists and methods of use App 20080113959 - Koppel; Gary A. | 2008-05-15 |
| {Beta}-Lactamyl vasopression V1a antagonists and methods of use App 20080090797 - Koppel; Gary A. ; et al. | 2008-04-17 |
| [Beta]-Lactamyl Vasopressin V1a Antagonists and Methods of Use App 20080033165 - Koppel; Gary A. ; et al. | 2008-02-07 |
| Neurotherapeutic composition and method therefor App 20070249523 - Koppel; Gary A. ; et al. | 2007-10-25 |
| .beta.-lactamyl vasopressin V.sub.1a antagonists Grant 7,268,125 - Bruns, Jr. , et al. September 11, 2 | 2007-09-11 |
| Neurotherapeutic Treatment For Sexual Dysfunction App 20070093466 - Koppel; Gary A. | 2007-04-26 |
| Therapeutic treatment for sexual dysfunction Grant 7,166,626 - Koppel January 23, 2 | 2007-01-23 |
| 3-Substituted beta-lactamyl vasopressin v1a antagonists App 20060281728 - Guillon; Christophe D.G. ; et al. | 2006-12-14 |
| .beta.-Lactamyl vasopressin V.sub.1a Antagonists Grant 7,119,083 - Bruns, Jr. , et al. October 10, 2 | 2006-10-10 |
| Beta-lactamyl vasopressin V1a antagonists App 20060217364 - Bruns; Robert F. JR. ; et al. | 2006-09-28 |
| Beta-lactamyl vasopressin v1aantagonists App 20040266750 - Bruns Jr, Robert F. ; et al. | 2004-12-30 |
| Neurotherapeutic composition and method App 20040229857 - Koppel, Gary A. | 2004-11-18 |
| Antibiotic composition and method App 20040072815 - Koppel, Gary A. | 2004-04-15 |
| Neurotherapeutic clavulanate composition and method App 20040014739 - Koppel, Gary A. | 2004-01-22 |
| Treatment of behavioral disorders with .beta.-lactam compounds Grant 6,627,625 - Koppel September 30, 2 | 2003-09-30 |
| Non-peptidyl vasopressin V1A antagonists Grant 6,610,680 - Bruns, Jr. , et al. August 26, 2 | 2003-08-26 |
| Neurotherapeutic clavulanate composition and method Grant 6,610,681 - Koppel August 26, 2 | 2003-08-26 |
| Neurotherapeutic composition and method therefor App 20030158172 - Koppel, Gary A. ; et al. | 2003-08-21 |
| Neurotherapeutic compositions App 20020183304 - Koppel, Gary A. | 2002-12-05 |
| Non-peptidyl vasopressin V1a antagonists App 20020049187 - Bruns, Robert F. JR. ; et al. | 2002-04-25 |
| Neurotherapeutic use of carboxypeptidase inhibitors App 20020028761 - Koppel, Gary A. ; et al. | 2002-03-07 |
| Use of beta-lactamase inhibitors as neuroprotectants App 20020002159 - Koppel, Gary A. | 2002-01-03 |
| Non-peptidyl vasopressin V1a antagonists Grant 6,204,260 - Bruns, Jr. , et al. March 20, 2 | 2001-03-20 |
| Cannabinoid receptor antagonists Grant 5,747,524 - Cullinan , et al. May 5, 1 | 1998-05-05 |
| Antibody drug-conjugates Grant 5,665,358 - Barton , et al. September 9, 1 | 1997-09-09 |
| Antibody-drug conjugates Grant 5,556,623 - Barton , et al. September 17, 1 | 1996-09-17 |
| Cluster conjugates of drugs with antibodies Grant 5,272,253 - Koppel , et al. December 21, 1 | 1993-12-21 |
| Immunoglobulin conjugates Grant 4,994,558 - Armour , et al. February 19, 1 | 1991-02-19 |
| Immunoglobulin conjugates of 2',2'-difluronucleosides Grant 4,814,438 - Armour , et al. March 21, 1 | 1989-03-21 |
| Ascorbic acid ethers in angiogene Grant 4,552,888 - Koppel , et al. November 12, 1 | 1985-11-12 |
| Substituted azetidin-2-one antibiotics Grant 4,144,232 - Koppel , et al. March 13, 1 | 1979-03-13 |
| Process for etherifying .beta.-lactam antibiotics Grant 3,994,885 - Koppel November 30, 1 | 1976-11-30 |
| 3-Thio-substituted cephalosporin antibiotics Grant 3,992,377 - Chauvette , et al. November 16, 1 | 1976-11-16 |
| 7-Methoxycephalosporins Grant 3,962,232 - Koppel June 8, 1 | 1976-06-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 